61689-40-5 Usage
Heterocyclic compound
Yes
The compound contains a ring structure with more than one type of atom, specifically sulfur, nitrogen, and oxygen.
Derivative of 1,3,4-oxathiazole
Yes
It is derived from the parent compound 1,3,4-oxathiazole, which is a five-membered ring containing sulfur, oxygen, and nitrogen atoms.
Ethyl ester group
Yes
The presence of an ethyl ester group (-COOCH2CH3) increases the lipophilicity of the molecule, potentially enhancing its drug-like properties.
Used in organic synthesis
Yes
The compound serves as a building block or intermediate in the synthesis of more complex organic molecules.
Pharmaceutical research
Yes
It is utilized in the development of new drugs and biologically active molecules due to its unique structure and properties.
Potential applications
Drug development
The compound's structure and properties make it an interesting target for further chemical and pharmacological investigations, with potential applications in the development of new therapeutic agents.
Enhanced drug candidate potential
Yes
Further chemical and pharmacological investigations
Recommended
The unique structure and properties of 1,3,4-OXATHIAZOLE-5-CARBOXYLIC ACID, 2-OXO-, ETHYL ESTER warrant further research to explore its full potential in drug development and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 61689-40-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,6,8 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 61689-40:
(7*6)+(6*1)+(5*6)+(4*8)+(3*9)+(2*4)+(1*0)=145
145 % 10 = 5
So 61689-40-5 is a valid CAS Registry Number.
61689-40-5Relevant articles and documents
COMPOUNDS AND COMPOSITIONS FOR EYE TREATMENTS
-
Page/Page column 227, (2020/07/04)
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that that generates cross-linking in the cornea in response to exposure to an electromagnetic irradiation. Th
4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
-
Page/Page column 31-32, (2008/06/13)
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia.
